İçeriğe geç

Sutent 50 mg Buy Capsules – Sunitinib

$490,00

Sutent 50 mg Capsules – Sunitinib by Pfizer is a powerful oral treatment for renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET), blocking tumor growth and improving survival outcomes.

Kategoriler: , Etiketler: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Sutent 50 mg Capsules by Pfizer is an advanced oral treatment containing the active ingredient Sunitinib. Sutent 50 mg Sunitinib is a targeted cancer therapy specifically designed to treat several types of tumors. Sutent 50 mg is primarily prescribed for patients diagnosed with renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).

Sutent 50 mg Sunitinib Capsules work as a multi-kinase inhibitor, targeting vascular endothelial growth factor receptors (VEGFR) and platelet-derived growth factor receptors (PDGFR). By blocking these pathways, Sutent 50 mg helps prevent the growth of new blood vessels that supply tumors, effectively reducing tumor growth and slowing cancer progression.

Due to its proven effectiveness and relatively manageable side effects, Sutent 50 mg Sunitinib is widely recognized as a gold-standard treatment in advanced cancer care.

🔥 Key Benefits & Uses of Sutent 50 mg Sunitinib:

  • Renal Cell Carcinoma (RCC): Sutent 50 mg Sunitinib is highly effective in treating advanced kidney cancer.
  • Gastrointestinal Stromal Tumors (GIST): Sutent 50 mg Sunitinib is used when patients become resistant to or intolerant of Imatinib.
  • Pancreatic Neuroendocrine Tumors (pNET): Sutent 50 mg Sunitinib is approved for patients with advanced pNET who are not suitable for surgery.
  • Anti-Angiogenic Effect: Sutent 50 mg blocks blood vessel formation around tumors, starving cancer cells and slowing progression.
  • Oral Administration: Sutent 50 mg Capsules provide a convenient oral treatment option for cancer patients.

💊 How to Use Sutent 50 mg Sunitinib:

  • Dosage: Sutent 50 mg is typically taken once daily for 4 weeks, followed by a 2-week break (6-week cycle).
  • Administration: Sutent 50 mg Capsules should be taken with or without food, swallowed whole with water.
  • Monitoring: Blood pressure, liver function, and complete blood counts should be regularly monitored during treatment.
  • Missed Dose: If a dose of Sutent 50 mg is missed, do not double the dose; continue with the next scheduled dose.

🧊 Storage Instructions:

  • Store Sutent 50 mg Capsules below 30°C.
  • Keep Sutent 50 mg Sunitinib in the original packaging to protect from moisture and light.
  • Keep out of reach of children.

⚠️ Potential Side Effects of Sutent 50 mg Sunitinib:

  • Fatigue and weakness.
  • Diarrhea, nausea, and vomiting.
  • Hypertension (high blood pressure).
  • Skin discoloration.
  • Hand-foot syndrome (redness, swelling, and pain on hands and feet).
  • Liver abnormalities.
    Patients should contact their healthcare provider if any severe side effects occur while using Sutent 50 mg Sunitinib.

🌍 Why Choose Sutent 50 mg Sunitinib by Pfizer?

  • Manufactured by Pfizer, a global leader in oncology treatments.
  • Multi-kinase inhibitor targeting multiple cancer pathways.
  • Proven success in treating RCC, GIST, and pNET.
  • Convenient once-daily oral capsule format.
  • Frequently prescribed as a first-line treatment in kidney cancer therapy.

✅ Real Patient Reviews:
“Sutent 50 mg Sunitinib has been a critical part of my kidney cancer treatment. It significantly slowed tumor growth and gave me precious time with my family.” – Patient Testimonial

🔗 Official Resource:
Pfizer Oncology Official Website – For detailed prescribing information and treatment guidelines.

Değerlendirmeler

Henüz değerlendirme yapılmadı.

“Sutent 50 mg Buy Capsules – Sunitinib” için yorum yapan ilk kişi siz olun

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir